Company & Sponsor Intelligence

National Healthcare Group, Singapore

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed2

Countries1

Therapeutic footprint

adhdautism

Indexed studies

NCT01344044Brain-Computer Interface (BCI) Based Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
adhd · SingaporePHASE2, PHASE3

NCT01031511Effect of Cognitive Behavioural Therapy (CBT) for Children With Autistic Spectrum Disorders
autism · SingaporeEARLY_PHASE1

NCT01695200Omega-3 Fatty Acids in Autism Spectrum Disorders
autism · SingaporePHASE4

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →